Commentary

Podcast

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

In this PER On Air Ophthalmology Times podcast, an expert panel discusses the latest advances in X-linked retinitis pigmentosa and how to optimize diagnosis as well as developments in gene therapy.

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

In this PER On Air Ophthalmology Times podcast, an expert panel discusses the latest advances in X-linked retinitis pigmentosa and how to optimize diagnosis as well as developments in gene therapy.

Mark Pennesi, MD, PhD, FARVO

Director, Ophthalmic Genetics, Retina Foundation, Professor of Ophthalmology, Professor of Molecular and Medical Genetics, Paul H. Casey Ophthalmic Genetics Division, Casey Eye Institute, Oregon Health & Science University, Dallas, TX

Laxmi V. Devisetty, MD

Ophthalmologist, Retina Specialist, Vitreoretinal Surgeon, NJRetina, Union, NJ

M. Dominik Fischer, MD, DPhil, FEBO, MRCOphth

Consultant Ophthalmologist Surgeon, Oxford Eye Hospital

Professor of Ophthalmology, University of Oxford, Oxford, England

Ramiro Maldonado, MD

Co-Director Pediatric Retina, Director IRD Fellowship, Ophthalmic Genetics Center, Duke University Eye Center, Durham, NC

Related Videos
Image credit: Ophthalmology Times; Angiogenesis 2025: Encapsulated cell therapy for MacTel shows long-term efficacy in phase 3 trials
Image credit: Ophthalmology Times; Dean McGee Eye Institute resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
Image credit: Ophthalmology Times; EnVision Summit 2025: Sonia H. Yoo, MD, shares what to expect from the cataract and refractive agenda
© 2025 MJH Life Sciences

All rights reserved.